Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin

References

• Petit L, Gibert M, Popoff MR. Clostridium perfringens: toxinotype and genotype. Trends Microbiol. 1999;7(3):104–110.
   PubMed Web of Science ®Google Scholar
• Uzal FA, Freedman JC, Shrestha A, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9(3):361–377.
   PubMed Web of Science ®Google Scholar
• Songer JG. Clostridial enteric diseases of domestic animals. Clin Microbiol Rev. 1996;9(2):216–234.
   PubMed Web of Science ®Google Scholar
• Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect. 2018;7:141.
   PubMed Web of Science ®Google Scholar
• Li J, Paredessabja D, Sarker MR, et al. Clostridium perfringens sporulation and sporulation-associated toxin production. Microbiol Spectr. 2016;4(3). DOI:10.1128/microbiolspec.TBS-0022-2015
   PubMed Web of Science ®Google Scholar
• Rood JI, Adams V, Lacey J, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;1–6. DOI:10.1016/j.anaerobe.2018.04.011
   Web of Science ®Google Scholar
• Li J, Adams V, Bannam TL, et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013;77(2):208–233.
   PubMed Web of Science ®Google Scholar
• Awad MM, Bryant AE, Stevens DL, et al. Virulence studies on chromosomal α-toxin and θ-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol. 1995;15(2):191–202.
   PubMed Web of Science ®Google Scholar
• Oda M, Kihara A, Yoshioka H, et al. Effect of erythromycin on biological activities induced by Clostridium perfringens α-toxin. J Pharm Exp Ther. 2008;327(3):934–940.
   PubMed Web of Science ®Google Scholar
• Sasaki J, Goryo M, Asahina M, et al. Hemorrhagic enteritis associated with Clostridium perfringens type A in a dog. J Vet Med Sci. 1999;61(2):175–177.
   PubMed Web of Science ®Google Scholar
• Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J Vet Diagn Invest. 2008;20(3):253–265.
   PubMed Web of Science ®Google Scholar
• Hough E, Hansen LK, Birknes B, et al. High-resolution (1.5Å) crystal structure of phospholipase C from Bacillus cereus. Nature. 1989;338(6213):357–360.
   PubMed Web of Science ®Google Scholar
• Titball RW. Clostridium perfringens vaccines. Vaccine. 2009;27(Suppl 4):D44–47.
   PubMed Web of Science ®Google Scholar
• Gillouard I, Garnier T, Cole ST. Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens. Infect Immun. 1996;64(7):2440–2444.
   PubMed Web of Science ®Google Scholar
• Bai JN, Zhang Y, Zhao BH. Cloning of α-β fusion gene from Clostridium perfringens and its expression. World J Gastroenterol. 2006;12(8):1229–1234.
   PubMed Web of Science ®Google Scholar
• Ellemor DM, Baird RN, Awad MM, et al. Use of genetically manipulated strains of Clostridium perfringens reveals that both alpha-toxin and theta-toxin are required for vascular leukostasis to occur in experimental gas gangrene. Infect Immun. 1999;67(9):4902–4907.
   PubMed Web of Science ®Google Scholar
• Martín R, Miquel S, Ulmer J, et al. Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease. Microb Cell Fact. 2013;12(1):71.
   PubMed Web of Science ®Google Scholar
• Perdigon G, Alvarez S, Rachid M, et al. Immune system stimulation by probiotics. J Dairy Sci. 1995;78(7):1597–1606.
   PubMed Web of Science ®Google Scholar
• Bosch M, Nart J, Audivert S, et al. Isolation and characterization of probiotic strains for improving oral health. Arch Oral Biol. 2012;57(5):539–549.
   PubMed Web of Science ®Google Scholar
• Yu M, Qi R, Chen C, et al. Immunogenicity of recombinant Lactobacillus casei expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK 63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice. J Appl Microbiol. 2017;122(2):506–515.
   PubMed Web of Science ®Google Scholar
• Marteau P, Rambaud JC. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev. 1993;12(1–3):207–220.
   PubMed Web of Science ®Google Scholar
• Grangette C, Muller-Alou H, Hols P, et al. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect Immun. 2004;72(5):2731–2737.
   PubMed Web of Science ®Google Scholar
• Wells JM, Mercenier A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 2008;6(5):349–362.
   PubMed Web of Science ®Google Scholar
• Ma S, Wang L, Huang X, et al. Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus. Microb Cell fact. 2018;17(1):20.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Y. Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization. Immunology. 2008;124(1):68–75.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang L, Ma S, et al. Immunogenicity of eGFP-marked recombinant Lactobacillus casei against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Viruses. 2017;9(10):274.
   Web of Science ®Google Scholar
• Wang X, Wang L, Huang X, et al. Oral delivery of probiotics expressing dendritic cell-targeting peptide fused with porcine epidemic diarrhea virus COE antigen: a promising vaccine strategy against PEDV. Viruses. 2017;9(11):312.
   Web of Science ®Google Scholar
• Freedman JC, Theoret JR, Wisniewski JA, et al. Clostridium perfringens type A-E toxin plasmids. Res Microbiol. 2015;166(4):264–279.
   PubMed Web of Science ®Google Scholar
• Olins PO, Rangwala SH. A novel sequence element derived from bacteriophage T7 mRNA acts as an enhancer of translation of the lacZ gene in Escherichia coli. J Biol Chem. 1989;264(29):16973–16976.
   PubMed Web of Science ®Google Scholar
• Ashiuchi M, Soda K, Misono H. A poly-γ-glutamate synthetic system of Bacillus subtilis IFO 3336: gene cloning and biochemical analysis of poly-γ-glutamate produced by Escherichia coli clone cells. Biochem Biophys Res Commun. 1999;263(1):6–12.
   PubMed Web of Science ®Google Scholar
• Ashiuchi M, Nawa C, Kamei T, et al. Physiological and biochemical characteristics of poly γ-glutamate synthetase complex of Bacillus subtilis. Eur J Biochem. 2001;268(20):5321–5328.
   PubMedGoogle Scholar
• Worbs T, Bode U, Yan S, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med. 2006;203(3):519–527.
   PubMed Web of Science ®Google Scholar
• Challacombe SJ, Rahman D, Jeffery H, et al. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology. 1992;76(1):164–168.
   PubMed Web of Science ®Google Scholar
• Wolf RC, Vasic N, Walte H. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science. 1972;177(4050):697–699.
   PubMed Web of Science ®Google Scholar
• Duerkop BA, Vaishnava S, Hooper LV. Immune responses to the microbiota at the intestinal mucosal surface. Immunity. 2009;31(3):368–376.
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Saito M, Usuku K, et al. A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurol Sci. 2005;237(1–2):75–81.
   PubMed Web of Science ®Google Scholar
• Magram J, Connaughton SE, Warrier RR, et al. IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses. Immunity. 1996;4(5):471–481.
   PubMed Web of Science ®Google Scholar
• Vancott JL, Staats HF, Pascual DW, et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol. 1996;156(4):1504–1514.
   PubMed Web of Science ®Google Scholar